FIELD: medicine, pharmaceutics.
SUBSTANCE: invention refers to pharmaceutical industry, particularly to a pharmaceutical composition for treating cardiomyopathy. The method for preparing the pharmaceutical composition for treating cardiomyopathy of Astragalus, wormseed, water plantain, ginseng or sylvan codonopsis, silk vine bark or acanthopanax, cinnamon, mandarin bark, aconite, salvia miltiorrhiza bunge, Youzhu, saflona. The pharmaceutical composition for treating cardiomyopathy (versions). The use of the pharmaceutical composition for preparing the drug preparation (versions).
EFFECT: above compositions are effective for treating cardiomyopathy.
11 cl, 7 dwg, 4 tbl, 4 ex
Title | Year | Author | Number |
---|---|---|---|
METHOD FOR TREATMENT OF HEART FAILURE AND DESTRUCTION OF NERVE CELLS | 2012 |
|
RU2615767C2 |
THERAPEUTIC AGENT FOR THE TREATMENT OF CARDIOMYOPATHY, PREVIOUS MYOCARDIAL INFARCTION AND CHRONIC HEART FAILURE | 2018 |
|
RU2795320C2 |
APPLICATION OF DIPEPTIDYLPEPTIDASE IV INHIBITORS | 2004 |
|
RU2385723C2 |
RESOURCE-SAVING METHOD OF PRODUCTION OF DRY EXTRACT FROM CEYLON CINNAMON BARK | 2013 |
|
RU2526165C1 |
COMPOSITIONS AND METHODS FOR CARDIAC FAILURE TREATMENT | 2012 |
|
RU2646481C2 |
COMPOSITIONS AND METHODS FOR TREATING HEART FAILURE IN DIABETIC PATIENTS | 2012 |
|
RU2650635C2 |
METHOD OF TREATMENT OF PATIENTS WITH INSULIN-DEPENDENT DIABETES MELLITUS AND MEDICINAL SPECIES FOR TREATMENT OF PATIENTS WITH INSULIN-DEPENDENT DIABETES MELLITUS | 2000 |
|
RU2161039C1 |
COMBINED THERAPY FOR PATIENTS WITH NEUROLOGICAL DISORDERS AND CEREBRAL INFARCTION | 2007 |
|
RU2486914C2 |
VIP FRAGMENTS AND METHODS FOR USING THEM | 2006 |
|
RU2466738C2 |
METHOD FOR ALCOHOLIC CARDIOMYOPATHY SIMULATION | 2013 |
|
RU2646454C2 |
Authors
Dates
2013-05-27—Published
2008-06-13—Filed